sur Sonnet BioTherapeutics, Inc. (NASDAQ:SONN)
Sonnet BioTherapeutics to Present at EF Hutton Annual Global Conference
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN), a biopharmaceutical company specializing in targeted biologic drugs, announced its participation in the EF Hutton Annual Global Conference. This event is scheduled for May 15, 2024, at The Plaza Hotel in New York. Pankaj Mohan, Ph.D., the company's founder and CEO, along with Richard Kenney, M.D., Chief Medical Officer, and Jay Cross, Chief Financial Officer, will represent Sonnet at the conference on May 15th.
During the conference, the management team from Sonnet BioTherapeutics will also engage in one-on-one investor meetings throughout the day. Individuals interested in attending can register for the event online. This participation underscores Sonnet's commitment to advancing its position in the biopharmaceutical industry through its innovative biologic drugs and proprietary technologies.
R. H.Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés. Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Sonnet BioTherapeutics, Inc.